MRSA nares screening has excellent negative predictive value for MRSA pneumonia and results faster than culture. We sought to decrease vancomycin overuse by identifying patients at low risk for MRSA pneumonia using rapid polymerase chain reaction (PCR) as part of an automated pharmacy-based ...
Conclusions Nares screening for MRSA had a high specificity and NPV for ruling out MRSA SSI. MRSA nares screening is a valuable tool to streamline empiric antibiotic therapy, especially among patients with SSI who are not colonized with MRSA....
MRSA nares PCR screening for MRSA pneumonia has demonstrated high negative predictive value (NPV) (98.1%) for MRSA associated community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP). Studies evaluating MRSA nares PCR to predict MRSA infection involving other anatomical sites including ...
THE UTILITY OF THE MRSA NARES SCREENING TEST IN PREDICTING MRSA PNEUMONIA IN ICU PATIENTS: A RETROSPECTIVE ANALYSISdoi:10.1016/j.chest.2019.08.1031D. WashburnAlexander J FriedmanM. KazemianElsevierChest
Conclusions: The incidence of PNA infection especially secondary to MRSA is higher in MRSA nares culture positive compared to negative patients on ICU admission in this study. Also, the incidence of other body sites (excluding nares) being positive for MRSA as well as non-MRSA organisms ...
Rapid de-escalation of anti-MRSA therapy guided by S. aureus nares screening for patients with pneumonia: protocol of a randomized controlled trial (SNAP study)doi:10.3389/fmed.2024.1416904De Vita, EldaSegala, Francesco VladimiroCavallin, Francesco...
MRSA nasal screen has a high negative predictive value (NPV) for ruling out MRSA in pneumonia and other sites. We performed a medication utilization evaluation (MUE) for Vancomycin IV in DFI patients who had an MRSA nares screen to determine our own NPV of this test and feasibility to use ...
The MRSA nasal PCR assay is used to detect if a patient's nares are colonized with MRSA. Studies have found that this test has an excellent negative predictive value at ruling out MRSA pneumonia. In practice, there is reluctance to utilize this data to de-escalate vancomycin, possibly ...